Niva Bupa Health Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹2,251Cr
- +34.7% YoY
- +39.7% QoQ
- Net profit
- ₹159Cr
- −22.8% YoY
- Turned profitable QoQ
- Margin
- 8%
- −7 pp YoY
- +14 pp QoQ
Guidance rank: #1 of 4 in Insurance
See the sector's top 10 — free with your mobile number.
The short version
Niva Bupa expects continued strong growth, targeting approximately 25% growth annually over the next 2-3 years. Niva Bupa expects a continued strong growth trajectory with retail health growing around 17%-19% CAGR over the next 5 years.
From Niva Bupa Health's Q4 FY26 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Niva Bupa expects continued strong growth, targeting approximately 25% growth annually over the next 2-3 years.
- Projected Gross Written Premium (GWP) could reach around INR 15,000 - 16,000 crores, up from INR 9,433 crores in FY '26.
- Growth drivers include:
- Multichannel distribution expansion, including 58,000 new agents added recently.
- Diversifying product portfolio to cover nearly all income segments except the poorest.
- Expansion in Tier 3 and below cities via the Bharat strategy (virtual agency and bank distribution).
- Increased penetration in digital channels both proprietary and third-party.
- Industry-wise, retail health insurance is expected to grow at about 17%-19% CAGR over 5 years.
2 more points from Niva Bupa Health's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Niva Bupa Health said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Management emphasizes investment in technology, analytics, and Gen AI as key levers for cost optimization and operational efficiency.
- Focus on expanding distribution channels, including virtual agency and bank distribution, to drive growth.
- Solvency ratio remains healthy at 2.49, indicating strong capital position to potentially fund future investments as needed.
Top-ranked in Insurance
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Niva Bupa Health said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Niva Bupa Health said on order book & pipeline — free account, 30 seconds.
Niva Bupa Health — Quarterly revenue & net profit
Niva Bupa Health Q4 FY26 results — key figures
| ₹ Cr | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 2,251 | 1,671 | +34.7% | 1,611 | +39.7% |
| Operating profit (EBITDA) | 182 | 251 | -27.5% | -94 | — |
| Operating margin | 8% | 15% | -7 pp | -6% | +14 pp |
| Profit before tax | 181 | 206 | -12.1% | -88 | — |
| Net profit (PAT) | 159 | 206 | -22.8% | -88 | — |
| EPS (₹) | 0.86 | 1.13 | -23.9% | -0.47 | — |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹2.6K Cr, net profit ₹136 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Niva Bupa Health's management said in earlier quarters
Others in Insurance this season
- Max Financial (Q4 FY26)
Total APE (Annualized Premium Equivalent) for FY’26: Rs 10,502 crore, up 20% YoY from Rs 8,770 crore in FY’25 (Page 4). Key investor presentation takeaways from
- Star Health Insu (Q4 FY26)
Fresh retail business growth driven by both value and volume, with retail policies expanding by 11% YoY in Q4 FY26. Key concall takeaways from Star Health &…
- Go Digit General (Q4 FY26)
For fiscal years '25 and '26, retail health business is under 6% of total health segment, indicating room for growth. Key concall takeaways from Go Digit…
- Medi Assist Healthcare Services (Q4 FY26)
Core group business organic growth currently tracking at 8%-10% (same-store growth). Key concall takeaways from Medi Assist Healthcare Services's Q4 FY26 earnin
Potential multibaggers · Q2 FY27
Potential multibaggers in Insurance
on management's own guidance
- Max FinancialModerate growth2
- 1
- HDFC Life Insurance CompanyModerate growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Niva Bupa Health and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Niva Bupa Health Q4 FY26 results?
Niva Bupa expects continued strong growth, targeting approximately 25% growth annually over the next 2-3 years. Niva Bupa expects a continued strong growth trajectory with retail health growing around 17%-19% CAGR over the next 5 years.
What is Niva Bupa Health share price analysis?
Niva Bupa Health currently shows a neutral. The stock trades at a P/E of 84.5 with a market cap of ₹14,718 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Niva Bupa Health on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
